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The 50-kD CD2 (T11) molecule, originally defined as the sheep erythrocyte receptor,
playsan important rolein Tlymphocyte activationas well asin facilitating adhesion
between T lymphocytes and their cognate partners (1-5). Perturbation of the ex-
tracellulardomain ofCD2 by itsligand, LFA-3, orcertain anti-CD2 mAbs provides
signals that synergize to augment TCRmediated stimulation (6, 7) and initiates
a rapid turnover in polyphosphoinositide accompanied by an increase in cytosolic
free calcium concentration (8, 9). In addition, this same combination ofanti-CD2
antibodies (with orwithout LFA-3) induceslymphokine production from, and clonal
expansion of, resting T lymphocytes (10).
Recently, the primary structures ofhuman and murine CD2 were deduced from
cDNA andgenomic cloning(11-17). The predicted structure inboth species is a type
I integral membrane protein. In man, the mature protein consists ofa hydrophilic
185 amino acid extracellular segment, ahydrophobic 25 aminoacid transmembrane
segment and a 117 amino acid cytoplasmic domain. Thehighest degree ofhomology
between human and murine species is found in the cytoplasmic domain (59% at
the amino acid level) and in both species the cytoplasmic domain is unique with
respect to its multiple proline (21%) and basic residues and by secondary structural
predictions, suggesting that it has an extended nonglobular conformation. Thus,
unusual but conserved features among species including man, mouse, and rat sug-
gest an important role for the CD2 segment in signal transduction (11, 12, 18). For
this reason, we have performed a series ofdeletion mutation studies on the CD2
cytoplasmic domain in the present report.
Materials and Methods
Construction of Truncated and Mutated Human CD2 Molecules and Transfection into a Murine T
Cell Hybridoma.
￿
To construct truncated CD2 molecules, the human CD2 cDNA, PB2 (11),
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was digested with restriction enzymes Hph I, Ban II, Fok I, Stu I, and Ava 1, respectively,
and blunted with T4 DNA polymerase. The Hph I and Ban II digests were ligated to the
linker 5'-CTAAGGATCCTTAG-3', while the Fok I, Stu I, and Ava I digests were ligated to
the linker 5'-TAAGGATCCTTA-3' to regenerate the last amino acid, introduce a termina-
tion codon, and provide a Bam HI restriction recognition site. Subsequently, the DNAs were
inserted into the Bam HI site ofDOL vector (kindly provided by Dr. Thomas Roberts, Dana-
Farber Cancer Institute). The substitution mutants were generated by oligonucleotide-directed
in vitro mutagenesis as previously described (19). The full-length human cDNA PB2 insert
was subcloned into BamHI site of M13 mp18. The synthetic oligonucleotides used for muta-
genesis were 5'-CAGGCACCTAGTGATGAGCCCCCGCCTCCT3' for CD2 M271-2, which
changes the wild-type sequence CATCGT (His-Arg) into GATGAG (Asp-Glu), and 5'-
CCGCCTCCTGGAGATGAGGTTCAGCACCAG-3'for CD2 M278-9, which changes the
wild-type sequence CACCGT (His-Arg) into GATGAG (Asp-Glu) . The Bam HI fragment
of the replicative form of M13 mutant DNAs was subcloned into expressing vector DOL.
The plasmids containing full-length or modified CD2 cDNAs were isolated and sequenced
around the modified region by double-stranded sequencing before transfection by Cat`
precipitation into >G-2, a helper-free retrovirus packaging cell line. Both transiently expressed
and permanent viral stocks were used to infect the murine T cell hybridoma, 3DO54.8 (kindly
provided by P. Marrack, NationalJewish Hospital) (20) in the presence of8 Wg/ml polybrene
(Aldrich Chemical Co., Milwaukee, WI). Procedures for the growth of ~-2 cells, transfection
of cells, harvest of virus, and infection of cells were performed as described (21). Selection
was initiated 48 h after infection using 0.4 mg/ml G418 (Geneticin; Gibco, Grand Island,
NY), and wells containing single colonies were expanded. The G418 resistant clones were
screened by indirect immunofluorescence as described in the legend to Fig. 2, and positive
clones were further sorted on the Epics V cell sorter. Cells were maintained in RPMI 1640
(Gibco Laboratories) medium supplemented with 10% heat-inactivated FCS (Flow Labora-
tories, McLean, VA). 50 AM 2-ME, 1 mM sodium pyruvate, 2 MM L-glutamine, 1% penicillin-
streptomycin (Whittaker, M . A. Bioproducts, Walkersville, MD) and 0.4 mg/ml G418.
Flow CytometricAnalysis.
￿
For cytometric analysis, ascites were used at a 1 :200 dilution and
106 cell incubated for 30 min at 4°C. After washing in RPMI 1640 with 2° / o FCS, bound
antibodies were detected using a 1 :40 dilution of fluorescein-coupled goat anti-mouse IgG
as a second antibody (Meloy, Springfield, VA). 10,000 cells were analyzed per sample on
an Epics V cell sorter. Histograms represent the number of cells (ordinate) vs. logio fluores-
cence intensity (abscissa).
Immunoprecipitation of CD2 Molecules.
￿
10-20 x 106 cells were surface labeled with 1 mCi
1251 (IMS 30; Amersham Corp., Arlington Heights, IL) for 15 min at room temperature
using the lactoperoxidase method (11). Cell lysates were prepared in RIPA buffer containing
0.15 M NaCl, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM NaF, 1 mM PMSF, and
protease inhibitors. Cell lysates were precleared once with a formalin-fixed Staphylococcus aureus
suspension, then with Affigel protein A beads(Pharmacia Fine Chemicals, Piscataway, NJ)
coupled to an irrelevant antibody (anti-CD8; 21Thy2D3) before overnight incubation at 4°C
with the anti-CD2 (3T4-8B5) antibody coupled to beads. Immunoprecipitates were extensively
washed with RIPA buffer and run on a 10% SDS-PAGE after treatment with 5% 2-ME.
The gel was dried and the autoradiograph was exposed for 2 wk at -70°C with intensifying
screens.
Measurement of Cytosolic Cat' by Indo-1 Fluorescence.
￿
Cytosolic Cat' concentrations were de-
termined according to Grynkiewicz et al. (22). Briefly, 2 x 106 cells were loaded for 45 min
at 37°C with 2 Wg/ml of the acetylmethyl ester of indo-1 (Molecular Probes, Junction City,
OR) in 200 A1 of RPMI 1640 plus 2% FCS. Cells were diluted 10-fold before analysis on
an Epics V cell sorter. Upon Cat' binding, indo-1 exhibits changes in fluorescein emission
wavelengths from 480 to 410 nm (22). The ratioof410/480 nm indo-1 fluorescence was recorded
vs. real time and expressed in arbitrary units. One arbitrary unit represents -200 nM
[Ca2 `];. For each determination, the baseline was assayed by recording indo-l-loaded cells
for 1 min. AntiTll2 (1old24C1) and anti-T113 (lmono2A6) ascites were added at a 1 :100 final
dilution. The Ca" ionophore A23187 (Sigma Chemical Co., St. Louis, MO) was added at
a 1 Fig/ml final concentration.CHANG ET AL.
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Modulation of CD3 Molecules.
￿
To modulate the murine CD3 molecule from the surface
CD2 FL, cells were incubated overnight with the 145 2C11-purified antibody (20 l~g/ml) at
37°C. Cells were washed twice and an aliquot of the cell was used to evaluate the effect of
modulation on murine CD3 and human CD2 expression using a standard indirect im-
munofluorescence assay (with the 145 2C11 and 3T4-8B5 mAbs, respectively). Modulated
cells were loaded with indo-1 and cytosolic [Ca2+]i was followed upon various stimuli. Under
such conditions, CD2 FL unmodulated cells or cells modulated with the anti-human CD3
mAb (Leu4) showed a [Ca2+]; comparable to Fig. 3 a (not shown) when triggered via CD2 .
Proliferation ofCTLL-20 Cells.
￿
For quantitation of IL-2 production, 105 cells/well were in-
cubated in 96-well round-bottomed plates for 24 h in the presence of either ovalbumin (1
mg/ml final concentration) plus 105 A20-11 B lymphoma cells or antiT112 + anti T11 3 (as-
cites 1 :100) or culture medium. Incubation with the nonstimulatory combination of anti-
T11, + anti-T112 antibodies did not induce any detectable IL-2 production, while stimula-
tion with antiT112 + anti-T11 3 antibodies resulted in clear IL-2 secretion by CD2 FL cells.
Because addition ofPMA (Sigma Chemical Co.) was found to induce a substantial increase
in lymphokine production, 5 ng/mlfinalconcentration ofPMA was added to all experimental
samples including the media control. Subsequently, supernatants were harvested and titrated
in triplicate for their ability to support the growth of 10,000 CTLL-20 cells. Cultures were
pulsed after 24 h incubation with 1 p,Ci [3H]thymidine per well and harvested after an ad-
ditional overnight incubation at 37°C over glass fiber filters on a Mash apparatus. Filters
were dried and counted after addition of scintillation fluid on a a counter. Results are ex-
pressed as mean of triplicate determinations of cpm of [3H]thymidine incorporated. Stan-
dard deviations were generally <5-10% and results are representative of five independent
experiments.
Results and Discussion
To precisely characterize the functional and structural relationship of the cyto-
plasmic domain ofthe human CD2 molecule (Fig. 1 a), a series of deletion mutation
of the CD2 cDNA were produced, as shown in Fig. 1 6, encoding 98, 77, 43, 18,
and -3 amino acids out of the 117 predicted cytoplasmic CD2 amino acid residues.
Full-length cDNAs as well as modified cDNAs were obtained as described in Materials
and Methods and inserted into the retrovirus expression vector DOL (Fig. 1 c) under
the control of the MLV LTR promoter (24) and defective viruses were generated
(21). The murine T cell hybridoma 3DO54.8 cell line specific for ovalbumin in the
context of the H-2 (I-Ad) molecule (20) and lacking the human CD2 was then in-
fected with these defective retroviruses. G418-resistant clones were selected in the
presence of 0.4 mg/ml G418 and analyzed for surface CD2 expression using an in-
direct immunofluorescence assay with anti-T111 and anti-T112 antibodies on an Epics
V cell sorter. Multiple clones corresponding to each type of truncation and expressing
clearly detectable levels of surface CD2 were selected for further characterization.
Clones used in subsequent functional studies were designated based on the nature
oftheir CD2 cDNA retroviral insert: CD2 FL resulted from retroviral infection with
the full-length CD2 cDNA, while CD2 AC98, CD2 AC77, CD2 AC43, CD2 AC18,
and CD2 AC-3 resulted from infection with retroviruses containing the entire extra-
cellular and transmembrane segment of CD2 but only 98 or fewer of the 117 cyto-
plasmic residues. A representative pattern of reactivity with the anti-CD2 mAb is
shown in Fig. 2 a. All of these transfectants express comparable levels of CD2
(N5-10,000 copies/cell) except CD2 AC18, which expresses on the order of 50% the
copy number. The CD2 AC-3 transfectant expressed levels of CD2 comparable to
CD2 AC18. However, the surface expression of CD2 on AC-3 was unstable and did2076
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not allow functional analysis (data not shown). For each clone, similar reactivities
to those obtained with anti T11 1 were found using the anti-T11 2 antibody, while none
of the unactivated clones was stained by the antiT113 antibody (data not shown).
To prove that individual clonal recipients of the truncated CD2 cDNAs express
appropriately sized CD2 proteins, immunoprecipitation and SDS-PAGE analysis
of the corresponding 1211-labeled surface CD2 molecules was carried out. As ex-
pected, no human CD2 was immunoprecipitated from the murine 3DO54.8 cell
line. In contrast, a 53-kD band was identified in SDS-PAGE analysis of clone CD2
FL. Note that the 70 kD band in anti-CD2 precipitations is unrelated to CD2 as
it is present in the control immunoprecipitates. Furthermore, parallel analysis of
CD2 protein expressed by CD2 AC98, AC77, AC43, and AC18 revealed that the
molecular weights of surface CD2 (51, 47, 43, and 40 kD, respectively) correlated
well with the expected truncations (Fig. 2 b). Thus, the truncated C132 cDNAs in
DOLdirect protein synthesis ofthe variant CD2 forms on the surface ofthe murine
3DO54.8 cells.
Given that pertubationof theexternal domain of theCD2 molecule with a combi-CHANG ET AL.
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FIGURE 2 .
￿
Expression ofhumanCD2 moleculeson murineT cells. (a)Flow cytometric analysis
ofCD2expression on murineT cells . Indirect immunofluorescence assays were carried out using
the antiTll I mAb(3T4-8B5) (thick line) andcompared with an irrelevant antibody (1HT4-4E5)
(thin line) as background . (b) Immunoprecipitation ofCD2 from lysates of iodinated cell lines .
Immunoprecipitates were obtained from solubilized murineT cells usinga nonspecific (NS) an-
tibody (mouse anti-human CD8) or an anti-CD2 antibody directed against the Tll 1 epitope
and rununder reducing conditions over anSDS 10% polyacrylamide gel (PAGE) . The resulting
autoradiogram is shown . A contaminant band of 70 kD (as well as material resolving at 200
kD, not shown) was regularly detected in the autoradiograms despite extensive preclearing, as
previously reported by others (20) .
nation of anti-T112 + anti-T113 results in a rapid rise in [Ca2+]i linked to IL-2 gene
induction (1, 9), we examined whether such amitogenic combination ofmAbs was
effective in stimulation of CD2 FL as well as CD2 t,C cell lines . Fig . 3 a shows an
analysis of alteration in [Ca2+ ]i after stimulation with antiT112 + antiT113 in var-
ious cells lines as measured with a calcium sensitive dye indo-1 (22) and flow cyto-
metric analysis in real time . A clear rise in [Ca2+ ]i (N200nM increment) was ob-
served upon stimulation ofCD2 FL,CD2AC98 andCD2AC77 cells . The calcium
rise occurs within 2 min after adding the stimulating antibodies, most likely corre-
sponding to the time required for expression of the T113 epitope after antiT112 stim-
ulation, a phenomena observed previously for human T lymphocytes (1) . In con-
trast, CD2 t,C43 andCD2 AC18 clones were not triggered by anti-T112 + anti-T113
antibodies . As expected, the nontransfected line 313054.8 was also not stimulated.
Given that an immediate [Ca2+]i rise was observed after addition of the Cat+ iono-
phore A23187 (1 wg/ml, final concentration), it is clear that cells were loaded with
the fluorescent dye . These data establish that a significant rise in [Ca2+]i can be in-
duced through human CD2 structures expressed on the membrane of murine T
cellseven in the absence of the COOH-terminal 40 amino acid residues of theCD2
cytoplasmic segment. The present resultswith humanCD2 are consistent with two2078
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FIGURE 3 .
￿
Elevation in intracellular free calcium mediated byCD2 stimulation . (a) Measure-
ment of cytosolic Cat' by indo-1 fluorescence. Indo-1 fluorescence changes in real time histo-
grams of T cell lines . Black and open arrows correspond to addition of antiT112 + antiT113
antibodies andcalcium ionophore A23187, respectively . (b) Influence ofCD3 modulation on in-
duction of [Ca2,], elevation triggeredthrough thehuman CD2 molecule . Left panel represents
indirect immunofluorescence detection of murine CD3 andhumanCD2 molecule, respectively,
on the surface of unmodulated CD2 FL (top) and modulated CD2 FL (bottom). The latter was
incubated with the 145 2C11 monoclonal antibody overnight (28) . Right panel represents mea-
surement of [Ca2'] ; vs . time in modulated CD2 FL cells after stimulation with anti-T112 + anti-
T113 antibodies (filled arrow) or calcium ionophore (open arrow) .
independent reports . He et al . (25) demonstrated a requirement for thecytoplasmic
tail of rat CD2 to trigger a rise in [Ca2 ']i after transfection of rat CD2 in the human
Jurkat T cell line . Bierer et al . (26) demonstrated arequirement forthe cytoplasmic
tail ofhuman CD2 expressed in murine T cells for an IL-2 response to liposomes
containing both HLA-DR and LFA-3 molecules .
Since human CD2 function in humanT lymphocytes requires expression of the
CD3Ti af# complex (1, 3, 27), we examined whether the function of a humanCD2
molecule within a murine cell line was linked to murine CD3Ti . As shown in Fig.
3 b, modulation of the murine CD3 molecule by thehamsteranti-mouse CD3e an-
tibody (145 2C11) resulted in nearly complete loss of the CD3 molecule from the
cell surface of CD2 FL after incubation for 16 h at 37°C, while CD2 expressionCHANG ET AL .
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was unaltered or slightly increased. Such anti-CD3 modulatedCD2 FL cells were
no longer stimulated by antiT112 + antiT113 antibodies to increase [Ca2+ ]i . By con-
trast, the incubation of CD2 FL cells under similar conditions with anti-human
CD3 antibody (Leu4) did not have any effect (Materials and Methods). This result
suggests that regulation of theCD2 pathway byCD3Ti is intact in the cellular model
herein, further supporting the validity of this functional approach in the study of
the CD2 intracellular domain . We cannot, of course, exclude the possibility that
CD3 modulation leads to a generalized disruption of subsequent T cell activation .
We next examined if nuclear activation events includingIL-2 induction and sub-
sequent IL-2 secretion could be triggered throughthehumanCD2 molecule in mu-
rine CD2FL cells . To this end, clones were stimulated and IL-2 secretion into su-
pernatants assayed using the IL-2-dependent CTLL-20 cells (29). As shown in Fig.
4 a, supernatants from CD2FL or313054.8 cells stimulated with ovalbumin in the
presence of the H-2(1-Ad) expressing A20-11 B lymphoma are able to induce prolifer-
ation of the IL-2-dependent CTLL-20 cells in a comparable way . By contrast, the
FIGURE 4.
￿
Stimulation of IL-2 production through the humanCD2 molecule and its variants
forms on murineT cells. (a) Effect ofculture supernatants fromCD2 FL or 313054 .8 on prolifer-
ation ofCTLL-20 cells . Serial twofold dilutions ofculture supernatants from stimulated or unac-
tivated murine cells were tested for their capacity to support the growth of the IL-2-dependent
murine CTLL-20 cell line (29), as evaluated by [3H]thymidine incorporation. (b) IL-2 produc-
tion upon antigen (ovalbumin) or antiT112 + antiT113 stimulation . Under these experimental
conditions, the limit of detection for IL-2 was <4 U/ml . M represents the murine T cell line
CD2 M271-2 . Analysis ofIL-2 production by two independent clones oftheCD2 M278-9 provided
evidence that such cells could produce significant amounts ofIL-2 uponCD2 triggering (N50%
of the amount secreted upon antigen stimulation) . Experiments were performed as above, but
precise quantification of IL-2 production was obtained by running culture supernatants in par-
allel to a titration curve of rIL-2 (Biogen Laboratories, Cambridge, MA) .2080
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combination of antiT112 + antiT113 antibodies is effective in inducing IL-2 produc-
tion by CD2 FL cells but not the parental line 313054.8. Fig. 4 b shows that all
ofthe cell lines tested including CD2 FL, 313054.8, andthe CD2 AC series produce
a high amount of IL-2 (ranging from 30 to 100 U/ml, corresponding to a clonal
variation repeatedly observed) when stimulated with ovalbumin in the I-Ad context.
This result demonstrates the integrity of the IL-2 synthetic pathway in each clone.
Perhaps more importantly, after stimulation with anti-CD2 antibodies, the clones
CD2 FL, CD2 AC98, andCD2 AC77 produce comparable levels of IL-2, while trans-
fectants CD2 AC43 and CD2 AC18, like the untransfected 313054.8, are not trig-
gered through CD2. Analysis of five other independent clones expressing the AC43
CD2 molecule clearly established that these cells are not triggered through human
CD2 either to secrete detectable levels of IL-2 or to elevate [Ca2+]; (datanot shown).
Taken together, these data show that a full-length human CD2 molecule, as well
as a CD2 molecule lacking 19 or 40 COOH-terminal amino acids from the cyto-
plasmic domain, is able to activate T lymphocytes after appropriate perturbation
of theCD2 extracellular segment. Interestingly, the CD2AC77 clones expresshuman
CD2 molecules lacking residues 289 to 316. The latter corresponds to the segment
most conserved among human and murine molecules, with 24 out of 27 residues
being identical (Fig. 1, a and b). Presumably, these conserved residues function in
another facet of CD2 biology unrelated to IL-2 induction and/or secretion. In con-
trast, theAC43 truncated moleculesas well as shortertruncations are nonfunctional
with respect to stimulating a rise in [Ca2']; and IL-2 production.
These data provide unequivocal evidence that the CD2 cytoplasmic domain is
involved in signal transduction and that one essential sequence of the cytoplasmic
domain necessary for C132-mediated activation is located between amino acids 253
to 287. This region contains four histidines at amino acid positions 264, 271, 278,
and 282 and includes two tandemly repeated segments (PPPGHR, amino acids
260-265 and 274-279) (see Fig. 1, a and b). These histidine residues could represent
a binding site for an ion, cyclic nucleotide, or other small regulatory molecule.
To evaluate the role of the histidine residues, substitution mutants of CD2 were
produced by site-directed mutagenesis as described in Materials and Methods. Two
different categories ofmutantswith a stable CD2 surface expression were obtained:
CD2 M271-2 and CD2 M278-9 in which the positively charged histidine and argi-
nine residues at position 271 and 272 or 278 and 279 were replaced by negatively
charged aspartic acid and glutamic acid, respectively (Fig. 1 b). Functional charac-
terization of these two mutants shows that IL-2 production can be induced by anti-
T112 and anti-T113 antibodies to a level comparable to that of the CD2 FL clones
(Fig. 4 banddata notshown). Thus, aputative "cage, requiringfour histidine residues,
is not necessary for this CD2 activation. Furthermore, since the mutations at posi-
tion 278-279 alter the structure of the second repeat without affecting T cell activa-
tion, the m C0014-terminal repeat is not required. Therefore, it may be specu-
lated that perhaps only one PPPGHR sequence is necessary for induction of IL-2
activity. This notion can be tested by further site-directed mutagenesis studies. Al-
ternatively, the repeats and/or other histidine residues could function to regulate
CD2 interaction with cytoskeletal, plasma membrane, cytosolic, nuclear, or other
cellular components not examined by the present assays. It also remains to be deter-
minedif the CD2 cytoplasmic region influences the CD2 extracellular segment andCHANG ET AL.
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hence, interaction with LFA-3 . The present model system will be useful at addressing
these latter possibilities.
Summary
To evaluate those residues in the 117 amino acids ofthe CD2 cytoplasmic domain
required for transduction ofT lymphocyte activation signals, a full-length human
CD2 cDNA and a series of deletion and substitution mutants were inserted into
the ovalbumin-specific, I-Ad-restricted murine T cell hybridoma 3DO54.8 using a
retroviral system . The resulting cells express surface CD2 protein and unlike the
parental murine line, are reactive with murine anti-human CD2 antibodies . Anti-
T112 plus anti-T113 antibody stimulation of cells expressing a full-length CD2 cDNA
results in a characteristic rise in cytosolic-free calcium ([Cal+]i), and subsequent IL-
2 secretion that accompany CD2 stimulation in humanT lymphocytes . Transfec-
tants expressing CD2 AC98 and CD2 AC77, partially deleted CD2 molecules con-
taining the entire extracellular and transmembrane CD2 segments but only 98 and
77 amino acids of the cytoplasmic domain, respectively, are also activated by anti-
CD2 mAbs . In contrast, clones expressing more severely truncated CD2 structures,
CD2 AC43 and CD2OC18, are not stimulated . These data show that the cytoplasmic
domain plays an essential role in transduction of activation signals via CD2, and
that the segment between amino acid residues 253 and 278 is necessary for activa-
tion . This region contains two tandem repeats of the sequence PPPGHR, thought
to form part ofa putative cationic site . Disruption of the latter by site-directed muta-
genesis does not affect IL-2 gene induction, suggesting that only one of the repeats
is required for activating this function of the CD2 molecule .
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